Duintjer Tebbens, Radboud J <br/><br/>
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.  [electronic resource] 

 -  BMC infectious diseases  05 2016 
 - 231 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2334 
<br/><br/><label>Standard No.: </label>10.1186/s12879-016-1536-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Disease Outbreaks--prevention & control<br/>Global Health<br/>Humans<br/>Models, Theoretical<br/>Poliomyelitis--prevention & control<br/>Poliovirus--immunology<br/>Poliovirus Vaccine, Inactivated--administration & dosage<br/>Poliovirus Vaccine, Oral--administration & dosage<br/>Risk Management<br/>Serogroup